Two Sigma Investments’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,789
| Closed | -$38K | – | 2870 |
|
|
2022
Q3 | $38K | Sell |
18,789
-6,500
| -26% | -$13.1K | ﹤0.01% | 2287 |
|
|
2022
Q2 | $68K | Sell |
25,289
-10,800
| -30% | -$29K | ﹤0.01% | 2248 |
|
|
2022
Q1 | $121K | Sell |
36,089
-30,966
| -46% | -$104K | ﹤0.01% | 2372 |
|
|
2021
Q4 | $306K | Buy |
67,055
+48,226
| +256% | +$220K | ﹤0.01% | 2159 |
|
|
2021
Q3 | $116K | Buy |
+18,829
| New | +$116K | ﹤0.01% | 2377 |
|